Inhaled Nitric Oxide (iNO) Collaborative

Last modified by Lisa Stromquist on 2016/04/05 17:16


To establish a standardized approach for the delivery, utilization and weaning of Inhaled Nitric Oxide for neonatal and paediatric patients across Canada. This project will have a strong emphasis on quality and safe care for this specialized patient population.

In 2013 The Canadian Association of Paediatric Health Centres (CAPHC), in partnership with Medbuy Corporation established a National Collaborative to develop guidelines for the use of inhaled nitric oxide (iNO) in neonatal and paediatric patients.  This Collaborative included content experts: physicians, respiratory therapists, nurses and quality improvement leaders from across the country. 

CAPHC and the Inhaled Nitric Oxide Collaborative are proud to announce that the CAPHC Guidelines for Inhaled Nitric Oxide for both Neonates and Paediatrics: Dosing, Administration and Weaning, are now posted on the CAPHC Knowledge Exchange Network

We believe that the development and implementation of national standards will: 

  • Provide a focus for quality control and patient safety; 
  • Reduce variations in practice;
  • Promote efficient use of iNO; 
  • Result in cost savings 
Created by Ann Watkins on 2016/03/31 18:11

Latest Activity

22 Feb

19 Feb

18 Feb

12 Feb

10 Feb

05 Feb

26 Jan

25 Jan

22 Jan

21 Jan

18 Jan

14 Jan

07 Jan

05 Jan

04 Jan

23 Dec 2020

21 Dec 2020

16 Dec 2020

14 Dec 2020

08 Dec 2020

04 Dec 2020

01 Dec 2020

26 Nov 2020

24 Nov 2020

16 Nov 2020

12 Nov 2020

05 Nov 2020